Search Results - cheng-yong shen

HOME SEARCH RSS
1 Results Sort By:
Novel Target and New Breast Cancer Drugs for Chemo-Resistant Tumors
Researchers at AU discovered that Erbin, an ErbB2 interacting protein is necessary for the ErbB2-dependent growth of tumor cells. They prepared small peptides that disrupt the Erbin-ErbB2 interaction, increase ErbB2 degradation, and inhibit growth of tumor cells. Injection of the peptide into tumors in nude mice inhibit tumor growth.
Published: 5/11/2017   |   Inventor(s): Lin Mei, Wen-Cheng Xiong, Cheng-Yong Shen, Yanmei Tao, Shiwen Luo
Keywords(s):  
Category(s): Therapeutics
© 2019. All Rights Reserved. Powered by Inteum